Procept Biorobotics Corporation: Barclays initiates coverage with overweight rating and $30 target price
PRCT•Barclays initiated coverage of Procept Biorobotics Corporation with an overweight rating and a $30 target price.
Related News
Yorkville Ives initiates coverage of DocuSign with in-line rating, $72 target
DOCU•
Corebridge Financial: Mizuho raises target price to $40 from $38
CRBG•
Bernstein cuts Delta Air Lines target price to $100 from $106
DAL•
Yorkville Ives initiates Rivian coverage with outperform rating; target price $20.00
RIVN•
Yorkville Ives initiates coverage of Netflix with an in-line rating and $75 target
NFLX•